648 reports of this reaction
1.2% of all VORICONAZOLE reports
#20 most reported adverse reaction
MULTIPLE ORGAN DYSFUNCTION SYNDROME is the #20 most commonly reported adverse reaction for VORICONAZOLE, manufactured by Roerig. There are 648 FDA adverse event reports linking VORICONAZOLE to MULTIPLE ORGAN DYSFUNCTION SYNDROME. This represents approximately 1.2% of all 52,026 adverse event reports for this drug.
VORICONAZOLE has an overall safety score of 88 out of 100. Patients taking VORICONAZOLE who experience multiple organ dysfunction syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MULTIPLE ORGAN DYSFUNCTION SYNDROME is a less commonly reported adverse event for VORICONAZOLE, but still significant enough to appear in the safety profile.
In addition to multiple organ dysfunction syndrome, the following adverse reactions have been reported for VORICONAZOLE:
The following drugs have also been linked to multiple organ dysfunction syndrome in FDA adverse event reports:
MULTIPLE ORGAN DYSFUNCTION SYNDROME has been reported as an adverse event in 648 FDA reports for VORICONAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MULTIPLE ORGAN DYSFUNCTION SYNDROME accounts for approximately 1.2% of all adverse event reports for VORICONAZOLE, making it a notable side effect.
If you experience multiple organ dysfunction syndrome while taking VORICONAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.